Active Substance & Generic Molecule Directory
Clarithromycin in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Clarithromycin registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
26
Registered Brands
Availability in Malaysia:26 Prescription (MAL-A)
Showing 26 of 26 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL04091676AZ | AVEXUS FILM-COATED TABLET 250 MG | 250 mg 0 | Prescription (MAL-A) | XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD. | Compare → |
| MAL04091677AZ | AVEXUS FILM-COATED TABLET 500 MG | 500 mg | Prescription (MAL-A) | XEPA-SOUL PATTINSON (MALAYSIA) SDN. BHD. | Compare → |
| MAL09111743AZ | CLARANTA Tablet 500 mg | 500 mg 0 | Prescription (MAL-A) | Gopharma Sdn. Bhd. | Compare → |
| MAL20040981AZ | CLAREM 250 TABLET | 250MG | Prescription (MAL-A) | EUCOGEN SDN BHD | Compare → |
| MAL14055010AZ | Clarem Film-Coated Tablet 500 mg | 500mg 0 | Prescription (MAL-A) | EUCOGEN SDN BHD | Compare → |
| MAL26066029AZ | CLARIFIC (Clarithromycin Lyophilized Powder for Solution for Infusion 500mg) | 500.00 mg | Prescription (MAL-A) | MEDISPEC (M) SDN. BHD. | Compare → |
| MAL07124607AZ | Clarimycin Film Coated Tablet 250mg | 250 mg 0 | Prescription (MAL-A) | Y.S.P. INDUSTRIES (M) SDN. BHD. | Compare → |
| MAL07124609AZ | Clarimycin Film Coated Tablet 500mg | 500 mg 0 | Prescription (MAL-A) | Y.S.P. INDUSTRIES (M) SDN. BHD. | Compare → |
| MAL20046102ACZ | Clarithromycin HEC 500 mg Prolonged-release Tablets | 500 mg | Prescription (MAL-A) | MEDISPEC (M) SDN. BHD. | Compare → |
| MAL12010003AZ | Clarithromycin STELLA 500mg Film-Coated Tablet | 500.00 mg | Prescription (MAL-A) | STADPHARM SDN. BHD. | Compare → |
| MAL20033973AZ | CLARITROX 250 TABLET | 250MG | Prescription (MAL-A) | SM PHARMACEUTICALS SDN. BHD. | Compare → |
| MAL20034609AZ | CLARITROX 500 TABLET | 500MG/TABLET | Prescription (MAL-A) | SM PHARMACEUTICALS SDN. BHD. | Compare → |
| MAL24086020AZ | Claritrox Granules for Oral suspension 125mg/5ml | 125 mg 5 ml | Prescription (MAL-A) | SM PHARMACEUTICALS SDN. BHD. | Compare → |
| MAL24086021AZ | Claritrox Granules for Oral suspension 250mg/5ml | 250 mg 5 ml | Prescription (MAL-A) | SM PHARMACEUTICALS SDN. BHD. | Compare → |
| MAL10033130AZ | CRIXAN OD TABLETS 500 mg | 500 mg 0 | Prescription (MAL-A) | RANBAXY (MALAYSIA) SDN. BHD. | Compare → |
| MAL20032427AZ | CRIXAN TABLETS 250MG | 250MG | Prescription (MAL-A) | RANBAXY (MALAYSIA) SDN. BHD. | Compare → |
| MAL18086120ACZ | KLACID MR 500MG TABLET | 500mg 0 | Prescription (MAL-A) | ABBOTT LABORATORIES (M) SDN. BHD. | Compare → |
| MAL18106039ACZ | KLACID TABLET 500MG | 500 mg | Prescription (MAL-A) | ABBOTT LABORATORIES (M) SDN. BHD. | Compare → |
| MAL18046160AZ | KLAR 250 (Clarithromycin Tablets 250 mg) | 250.0mg | Prescription (MAL-A) | HEALOL PHARMACEUTICALS SDN. BHD. | Compare → |
| MAL18046161AZ | KLAR 500 (Clarithromycin Tablets 500 mg) | 500mg 0 | Prescription (MAL-A) | HEALOL PHARMACEUTICALS SDN. BHD. | Compare → |
| MAL05101667AZ | KLERIMED 250MG TABLET | 257.0 mg 0 | Prescription (MAL-A) | KOMEDIC SDN BHD | Compare → |
| MAL05101668AZ | KLERIMED 500MG TABLET | 515.50 mg 0 | Prescription (MAL-A) | KOMEDIC SDN BHD | Compare → |
| MAL06071053AZ | Maclar 250 Clarithromycin Tablets USP 250mg | 250.00 mg | Prescription (MAL-A) | Glenmark Pharmaceuticals (Malaysia) Sdn. Bhd. | Compare → |
| MAL06071052AZ | Maclar 500 Clarithromycin Tablets USP 500mg | 500.00 mg | Prescription (MAL-A) | Glenmark Pharmaceuticals (Malaysia) Sdn. Bhd. | Compare → |
| MAL20021383AZ | PHARMANIAGA CLARITHROMYCIN TABLET 250MG | 250.00MG | Prescription (MAL-A) | PHARMANIAGA MANUFACTURING BERHAD | Compare → |
| MAL20021384AZ | PHARMANIAGA CLARITHROMYCIN TABLET 500MG | 500.00MG | Prescription (MAL-A) | PHARMANIAGA MANUFACTURING BERHAD | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.